Group One Trading, L.P. Verona Pharma PLC Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Verona Pharma PLC stock. As of the latest transaction made, Group One Trading, L.P. holds 2,265 shares of VRNA stock, worth $66,205. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,265
Previous 12,672
82.13%
Holding current value
$66,205
Previous $203,000
84.24%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding VRNA
# of Institutions
137Shares Held
66.7MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$223 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$163 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$117 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$104 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$96.9 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $1.78B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...